Intervention of Interest
- cytisinicline (Achieve Life Sciences, Inc.)
For questions please contact info@icer.org.
View the Key Stakeholder List.
Smoking Cessation
An assessment of cytisinicline
Public Meeting
January 2026
Assessment Status
Open
Upcoming Milestone
Revised Scoping DocumentView
Main Review
January 15, 2026
Midwest CEPAC
The Midwest CEPAC’s 2025 public meeting on cytisinicline
Public Comment Period
See Full Timeline
05/20/2025 - 06/10/2025
Public Comments on Draft Scoping Document
Related Assessments & Policy Papers.
06/30/2025
Revised Scoping Document
07/09/2025
Research Protocol
Please find the research protocol here:
08/21/2025
Model Analysis Plan
12/11/2025
Evidence Report
01/15/2026
Evidence Presentation
02/12/2026
Public Comments
OpenView
Closed